Neurodegeneration with brain iron accumulation (NBIA)

Definition

Neurodegeneration with brain iron accumulation (NBIA) are a group of very rare nervous system disorders. They are passed down through families (inherited). NBIA involves movement problems, dementia, and other nervous system symptoms.

Alternative Names

Hallervorden-Spatz disease; Pantothenate kinase-associated neurodegeneration; PKAN; NBIA

Causes

Symptoms of NBIA begin in childhood or adulthood.

There are 10 types of NBIA. Each type is caused by a different gene variant. The most common gene variant causes the disorder called PKAN (pantothenate kinase-associated neurodegeneration).

People with all forms of NBIA have a buildup of iron in an area deep inside the brain called the basal ganglia as well as other areas of the brain that help regulate movements.

Symptoms

NBIA mainly causes movement problems. Other symptoms may include:

Exams and Tests

Your health care provider will perform a physical exam and ask about symptoms and medical history.

Genetic tests can look for the variant gene that causes the disease. However, these tests aren't widely available.

Tests such as an MRI scan can help check for other movement disorders and diseases. The MRI usually shows iron deposits in the basal ganglia, and are called the "eye of the tiger" sign because of the way the deposits look in the scan. This sign suggests a diagnosis of PKAN.

Treatment

There is no specific treatment for NBIA. Treatment is mainly focused on regulating the symptoms. The most commonly used medicines to regulate symptoms include baclofen and trihexyphenidyl.

Outlook (Prognosis)

NBIA damages the nerves over time and symptoms get worse. It leads to a lack of movement, and often death by early adulthood.

Possible Complications

Medicine used to treat symptoms can cause complications. Being unable to move due to the disease can lead to:

When to Contact a Medical Professional

Contact your provider if your child develops:

Prevention

Genetic counseling may be recommended for families affected by this illness. There is no known way to prevent it.

References

Jankovic J. Parkinson disease and other movement disorders. In: Jankovic J, Mazziotta JC, Pomeroy SL, Newman NJ, eds. Bradley and Daroff's Neurology in Clinical Practice. 8th ed. Philadelphia, PA: Elsevier; 2022:chap 96.

NBIA Disorders Association website. Overview of NBIA disorders. www.nbiadisorders.org/about-nbia/overview-of-nbia-disorders. Accessed August 20, 2024.


Review Date: 8/19/2024
Reviewed By: Joseph V. Campellone, MD, Department of Neurology, Cooper Medical School at Rowan University, Camden, NJ. Review provided by VeriMed Healthcare Network. Also reviewed by David C. Dugdale, MD, Medical Director, Brenda Conaway, Editorial Director, and the A.D.A.M. Editorial team.
The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. No warranty of any kind, either expressed or implied, is made as to the accuracy, reliability, timeliness, or correctness of any translations made by a third-party service of the information provided herein into any other language. © 1997- A.D.A.M., a business unit of Ebix, Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
© 1997- adam.comAll rights reserved.